Prognostic significance of PNH clones in aplastic anemia treated with immunosuppression or allogeneic HSCT: a 20-year single-center experience

Abstract Background Paroxysmal nocturnal hemoglobinuria (PNH) clones are detected in up to 60% of patients with aplastic anemia (AA); however, their prognostic impact remains incompletely defined, particularly in the context of frontline immunosuppressive therapy (IST) or allogeneic hematopoietic st...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Alfadil Haroon, Hazzaa Alzahrani, Mostafa F. Mohammed Saleh, Ali Aalahmari, Shaykhah Alotaibi, Tusneem Elhassan, Feras Alfraih, Fahad Alsharif, Syed O. Ahmed, Fahad Almohareb, Riad El Fakih, Mahmoud Aljurf
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer Nature 2026-04-01
Edice:	Blood Research
Témata:	Aplastic anemia PNH clone Immunosuppressive therapy Allogeneic stem cell transplantation Prognosis GVHD
On-line přístup:	https://doi.org/10.1007/s44313-026-00136-3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!